Long-term Dynamics of Measles Virus–Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age
Routine vaccination of infants under 8.5 months of age may lead to blunted MeV-specific antibody responses to subsequent MMR vaccination. Early MMR vaccination should only be considered during measles outbreaks or in other situations of increased risk of MeV infection. Clinical Trials Registration. EudraCT 2013-003078-28.
Authors
- Gaby Smits (ORCID: https://orcid.org/0000-0003-4890-0940)
- Rik L. de Swart (ORCID: https://orcid.org/0000-0003-3599-8969)
- Nynke Y. Rots (ORCID: https://orcid.org/0000-0002-7170-7826)
- Mioara Alina Nicolaie (ORCID: https://orcid.org/0000-0001-8468-921X)
- Hinke I ten Hulscher
- Rob van Binnendijk (ORCID: https://orcid.org/0000-0002-5808-1443)
- Jelle de Wit (ORCID: https://orcid.org/0000-0003-2444-6050)
- M Staak
Institutions
- Erasmus MC (NL)
- National Institute for Public Health and the Environment (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1093/cid/ciae537
- Citations
- 12
- Primary Topic
- Virology and Viral Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.64
Funders
- Ministerie van Volksgezondheid, Welzijn en Sport